Domov › Akutna bifentipska levkemija › Washington › Seattle

Klinične študije za Akutna bifentipska levkemija v Seattle, WA

15 študij za Akutna bifentipska levkemija išče udeležence na lokacijah v Seattle in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Vključevanje udeležencevFaza 1

Fred Hutchinson Cancer Center, Seattle

Starost 12–78 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT03802695

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Vključevanje udeležencevFaza 2

Seattle Children's Hospital, Seattle

365 Days · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06317662

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Vključevanje udeležencevFaza 1

Fred Hutch/University of Washington Cancer Consortium, Seattle

Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT04375631

Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

Vključevanje udeležencev

Fred Hutch/University of Washington Cancer Consortium, Seattle

Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07094750

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Vključevanje udeležencevFaza 3

Seattle Children's Hospital, Seattle

365 Days – 25 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Vključevanje udeležencevFaza 1/2

Seattle Children's Hospital, Seattle

Do 22 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04726241

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Vključevanje udeležencevFaza 2

Fred Hutch/University of Washington Cancer Consortium, Seattle

6 Months – 65 Years · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT06013423

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

Vključevanje udeležencevFaza 2

Fred Hutch/University of Washington Cancer Consortium, Seattle

Starost 18 in več · Vsi spoli · Posodobljeno 20. jul. 2026 · NCT07046078

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

Vključevanje udeležencevFaza 1/2

Fred Hutch/University of Washington Cancer Consortium, Seattle

Starost 18–75 · Vsi spoli · Posodobljeno 22. jun. 2026 · NCT03128034

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Vključevanje udeležencevFaza 1/2

Fred Hutch/University of Washington Cancer Consortium, Seattle

Starost 18–75 · Vsi spoli · Posodobljeno 22. jun. 2026 · NCT03670966

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci

Fred Hutch/University of Washington Cancer Consortium, Seattle

6 Months · Vsi spoli · Posodobljeno 29. maj 2026 · NCT04195633

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Vključevanje udeležencevFaza 1

Fred Hutch/University of Washington Cancer Consortium, Seattle

Do 80 let · Vsi spoli · Posodobljeno 18. maj 2026 · NCT03326921

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Vključevanje udeležencevFaza 1/2Vabljeni zdravi prostovoljci

Fred Hutch/University of Washington Cancer Consortium, Seattle

Starost 18 in več · Vsi spoli · Posodobljeno 15. maj 2026 · NCT06928662

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

Vključevanje udeležencevFaza 1/2

Fred Hutch/University of Washington Cancer Consortium, Seattle

Starost 18 in več · Vsi spoli · Posodobljeno 17. apr. 2026 · NCT04797767

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Vključevanje udeležencevFaza 1

Seattle Children's Hospital, Seattle

Starost 1–21 · Vsi spoli · Posodobljeno 6. dec. 2024 · NCT05476770

Študije za Akutna bifentipska levkemija v drugih mestih

Druge študije v Seattle

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.